Jim Simons Celcuity Inc. Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Celcuity Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 74,856 shares of CELC stock, worth $1.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

74,856

Previous 26,056 187.29%

Holding current value

$1.23 Million

Previous $380,000 325.53%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$13.74 - $21.6 $670,512 - $1.05 Million	48,800 Added 187.29%	74,856 $1.62 Million
Q4 2023 Feb 13, 2024	SELL	$8.7 - $15.02 $869 - $1,502	-100 Reduced 0.38%	26,056 $380,000
Q3 2023 Nov 14, 2023	SELL	$8.96 - $10.75 $43,904 - $52,675	-4,900 Reduced 15.78%	26,156 $239,000
Q2 2023 Aug 11, 2023	BUY	$9.39 - $12.18 $20,658 - $26,796	2,200 Added 7.62%	31,056 $341,000
Q1 2023 May 12, 2023	SELL	$9.4 - $12.82 $24,440 - $33,332	-2,600 Reduced 8.27%	28,856 $296,000

Q4 2022 Feb 13, 2023	SELL	$7.55 - $14.01 $189,505 - $351,651	-25,100 Reduced 44.38%	31,456 $441,000
Q3 2022 Nov 14, 2022	SELL	$8.0 - $10.64 $233,600 - $310,688	-29,200 Reduced 34.05%	56,556 $568,000
Q2 2022 Aug 12, 2022	BUY	$5.35 - $10.11 $60,989 - $115,254	11,400 Added 15.33%	85,756 $780,000
Q1 2022 May 13, 2022	BUY	$7.93 - $13.33 $347,334 - $583,854	43,800 Added 143.34%	74,356 $695,000
Q4 2021 Feb 11, 2022	BUY	$11.96 - $19.35 $60,996 - $98,685	5,100 Added 20.03%	30,556 $403,000
Q3 2021 Nov 12, 2021	SELL	$17.35 - $24.87 $152,680 - $218,856	-8,800 Reduced 25.69%	25,456 $458,000
Q2 2021 Aug 13, 2021	SELL	$14.25 - $30.93 $377,625 - $819,645	-26,500 Reduced 43.62%	34,256 $822,000
Q1 2021 May 13, 2021	BUY	$10.43 - $17.8 $83,909 - $143,201	8,045 Added 15.26%	60,756 $871,000
Q4 2020 Feb 10, 2021	SELL	$5.13 - $11.72 $1,246 - $2,847	-243 Reduced 0.46%	52,711 $483,000
Q3 2020 Nov 13, 2020	SELL	$5.1 - $7.07 $2,784 - $3,860	-546 Reduced 1.02%	52,954 $307,000
Q2 2020 Aug 13, 2020	SELL	$4.42 - $11.04 $35,183 - $87,878	-7,960 Reduced 12.95%	53,500 $371,000
Q1 2020 May 14, 2020	BUY	$5.79 - $11.78 $151,466 - $308,164	26,160 Added 74.11%	61,460 $399,000
Q4 2019 Feb 13, 2020	BUY	$9.47 - $16.71 $334,291 - $589,863	35,300 New	35,300 $376,000

Others Institutions Holding CELC

# of Institutions

Shares Held

22.9M

Call Options Held

24.9K

Put Options Held

View Full List

About Celcuity Inc.

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $246M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

More about CELC

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account